ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in NBP — NovaBridge Biosciences

CIK 1165408 Boston, MA

Position in NBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,460,000

-$1,520,000 QoQ

Shares Held

1,000,000

0.0% QoQ

Ownership

0.377%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,595,586,445 across 121 Biotechnology names. NBP ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,475,611	$532,503,169
2	RPRX	Royalty Pharma plc	7,480,633	$358,845,965
3	CNTA	Centessa Pharmaceuticals plc	8,925,010	$354,501,397
4	ROIV	Roivant Sciences Ltd.	12,794,097	$354,396,486
5	TNGX	Tango Therapeutics, Inc.	12,809,485	$267,974,426
6	PRAX	Praxis Precision Medicines, Inc.	815,739	$262,822,948
7	INSM	INSMED Inc	900,000	$147,168,000
8	AXSM	Axsome Therapeutics, Inc.	737,578	$124,665,433

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,460,000	1,000,000	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,980,000	1,000,000	-70.0%	Shares	Sole	2026-02-17
2025-09-30	$12,617,768	3,338,034	+270.9%	Shares	Sole	2025-11-14
2022-06-30	$10,170,000	900,000	-35.7%	Shares	Sole	2022-08-15
2022-03-31	$22,736,000	1,400,000	0.0%	Shares	Sole	2022-05-16
2021-12-31	$66,346,000	1,400,000	+16.7%	Shares	Sole	2022-02-14
2021-09-30	$86,981,185	1,199,906	+45.5%	Shares	Sole	2021-11-15
2021-06-30	$69,250,858	824,906	-32.2%	Shares	Sole	2021-08-16
2021-03-31	$58,973,158	1,216,694	-13.4%	Shares	Sole	2021-05-17
2020-12-31	$66,212,745	1,404,300	+19.0%	Shares	Sole	2021-02-16
2020-09-30	$55,498,786	1,180,072	+5.6%	Shares	Sole	2020-11-16
2020-06-30	$33,441,297	1,117,317	+11.7%	Shares	Sole	2020-08-14
2020-03-31	$13,000,000	1,000,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.